Cohen Veterans Bioscience

Cohen Veterans Bioscience to build wellness platform for brain disorders

Monday, October 2, 2017

Cohen Veterans Bioscience and Early Signal Foundation announce a partnership to advance the use of wearable and home sensors for real-time monitoring of patients with trauma-related and other brain disorders. Early Signal Foundation, a nonprofit organization focused on disruptive health solutions for rare disorders and underserved populations, will provide an affordable analytical system to record and integrate behavioral, cognitive, physiological and contextual data.

[Read More]

Cohen Veterans Bioscience, Stanford University partner on PTSD

Wednesday, October 19, 2016

Despite many years of pioneering work characterizing the brains, behavior, and physiology of individuals with post-traumatic stress disorder (PTSD), the field of psychiatry lacks objective biological measures for understanding the many biological variations in people with the same clinical diagnosis of PTSD. This means that there are no reliable ways to determine who will benefit from which treatment. A new collaboration between Cohen Veterans Bioscience and Stanford University School of Medicine seeks to change this by studying clinical biomarkers as a way to help match patients to the best available treatment.

[Read More]